About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 374 record(s)
Req # A-2023-000682
Adverse Drug Reactions (ADRs). Report numbers: 001043664, 001044182, 001044190, 001044321, 001046945, 001047019, 001049636.Organization: Health Canada
September 2023
Req # A-2023-000701
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 23-105124-593.Organization: Health Canada
September 2023
Req # A-2023-000712
Adverse Drug Reaction (ADR). Report number: 001036984.Organization: Health Canada
September 2023
Req # A-2023-000770
Adverse Drug Reaction (ADR). Report number: 001036980.Organization: Health Canada
September 2023
Req # A-2023-000774
Adverse Drug Reaction (ADR). Report number: 001045682.Organization: Health Canada
September 2023
Req # A-2023-000787
Adverse Drug Reaction (ADR) for CHLORHEXIDINE. Report number: 001036984.Organization: Health Canada
September 2023
Req # A-2023-001
Records from May 1st to the 8th, 2023 - Transition to King Charles III on Canadian coins.Organization: Royal Canadian Mint
September 2023
Req # A-2019-001009
Adverse Drug Reactions (ADRs) for Chlorhexidine. Report numbers: 000725334, 000725411, 000725428, 000725434, 000725439, 000725442, 000725446, 000725500, 000725506, E2B_02466826, E2B_02467708, E2B_02467710, E2B_02469532, E2B_02479840, 000725624, 000725643, 000725711, 000725770, 000725821, 000725822, 000725824, E2B_02535786. ADRs for Nicotine. Report numbers: 000723298, E2B_02446830, E2B_02456263, E2B_02478261, E2B_02478354, E2B_02487552, E2B_02491357,E2B_02494777, E2B_02508747, E2B_02532088.Organization: Health Canada
September 2022
Req # A-2019-001729
Adverse Drug Reactions (ADRs) for immunoglobulin (human). Report numbers: 000729698, 000729737, 000729753, E2B_02721074, E2B_02725284, E2B_02745409, E2B_02745430, E2B_02757454, E2B_02757460, E2B_02757483, E2B_02758498, E2B_02758510, E2B_02761164, E2B_02761166, E2B_02762212, E2B_02770935, E2B_02790551, E2B_02790674, E2B_02791333, E2B_02806975.Organization: Health Canada
September 2022
Req # A-2020-000935
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-109891-294.Organization: Health Canada
September 2022